Correction to: Leukemia (2006) 20, 1467–1473. doi:10.1038/sj.leu.2404284
It has been identified by the authors that there was an error in the author list. The following author was omitted in error.
M Cavo, Institute of Hematology and Medical Oncology ‘Seràgnoli’, University of Bologna, Italy.
The corrected list is mentioned here.
BGM Durie, J-L Harousseau, JS Miguel, J Bladé, B Barlogie, K Anderson, M Gertz, M Dimopoulos, J Westin, P Sonneveld, H Ludwig, G Gahrton, M Beksac, J Crowley, A Belch, M Boccadaro, M Cavo, I Turesson, D Joshua, D Vesole, R Kyle, R Alexanian, G Tricot, M Attal, G Merlini, R Powles, P Richardson, K Shimizu, P Tosi, G Morgan and SV Rajkumar on behalf of the International Myeloma Working Group.
The authors apologize for any inconvenience caused.
Author information
Consortia
Additional information
The online version of the original article can be found at 10.1038/sj.leu.2404284
Rights and permissions
About this article
Cite this article
Durie, B., Harousseau, JL., Miguel, J. et al. Erratum: International uniform response criteria for multiple myeloma. Leukemia 20, 2220 (2006). https://doi.org/10.1038/sj.leu.2404428
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2404428
This article is cited by
-
Bortezomib administered pre-auto-SCT and as maintenance therapy post transplant for multiple myeloma: a single institution phase II study
Bone Marrow Transplantation (2009)
-
Clinically relevant end points and new drug approvals for myeloma
Leukemia (2008)
-
Initial Therapy of Multiple Myeloma in Patients who are Candidates for Stem Cell Transplantation
Current Treatment Options in Oncology (2007)
